Laboratory Products
Innovative Connective Tissue Disease Screen
Apr 28 2010
Phadia has launched an innovative new antinuclear antibody (ANA) screen for identification of connective tissue diseases (CTDs). The EliA ANA CTD Screen provides reliable and unambiguous detection of a wide range of
CTDs, offering superior specificity and sensitivity to HEp-2 based assays, even in difficult cases. It is designed to meet the needs of routine diagnostic testing, and is fully compatible with the ImmunoCAP automated laboratory systems for straightforward integration into laboratory workflows.
The screen uses a unique combination of concentrated and highly specific recombinant antigens to offer excellent sensitivity, with fewer false positives, and exceptional intra- and inter-laboratory reproducibility, ensuring simple data interpretation. In addition, the EliA ANA CTD Screen can be used alongside HEp-2 cellular techniques to provide valuable supplementary information in complex cases. By combining virtually all the relevant ANAs for CTDs in a single test, the screen provides clinicians with unambiguous and diagnostically relevant information, reducing
requirements for follow-up testing and improving patient outcomes.
Digital Edition
Lab Asia 31.4 August 2024
August 2024
Chromatography Articles - HPLC gradient validation using non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers Labo...
View all digital editions
Events
Sep 04 2024 Chiba, Tokyo, Japan
Sep 04 2024 University of Warwick, Coventry, UK
Sep 11 2024 Bangkok, Thailand
Sep 11 2024 Singapore
Sep 11 2024 Bangkok, Thailand